Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging.

Healthy aging is associated with reductions in appetite and food intake--the so-called anorexia of aging, which may predispose to protein-energy malnutrition. One possible cause of the anorexia of aging is an increased satiating effect of cholecystokinin (CCK). To investigate the impact of aging on the satiating effects of CCK, 12 young and 12 older healthy subjects received 25-min iv infusions of saline (control) and CCK-8, 1 ng/kg per min or 3 ng/k per min, on 3 separate days before a test meal. Older subjects ate less than young subjects, and food intake was suppressed 21.6% by CCK-8, compared with the control day (P < 0.05). The suppression of energy intake by CCK-8 in older subjects was twice that in young subjects (32 +/- 6% vs. 16 +/- 6% SEM, P < 0.05) and was related to plasma CCK-8 concentrations, which were higher at baseline (P < 0.05) and increased more during CCK-8 infusions in older than young subjects (P < 0.01). The extent of suppression of food intake per given rise in plasma CCK-8 concentrations did not differ between the two age groups (P = 0.35). Endogenous CCK concentrations were higher at baseline in older subjects (P < 0.001) and decreased during the CCK-8 but not control infusions (P < 0.01), suggesting that CCK suppresses its own release. Plasma leptin concentrations were not affected by CCK infusion, whereas postprandial insulin concentrations were lowered and the peak postprandial glucose concentration was delayed but not affected by CCK-8 infusion. Because older people retain their sensitivity to the satiating effects of exogenous CCK and plasma endogenous CCK concentrations are higher in older people, increased CCK activity may contribute to the anorexia of aging.

[1]  J. Holst,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Antidiabetogenic Action of Cholecystokinin-8 in Type 2 Diabetes* , 2022 .

[2]  C. Beglinger,et al.  Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  J. Wishart,et al.  Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. , 1999, The American journal of clinical nutrition.

[4]  M. Porrini,et al.  Physical state of meal affects gastric emptying, cholecystokinin release and satiety , 1998, British Journal of Nutrition.

[5]  J. Blundell,et al.  Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion , 1998, Physiology & Behavior.

[6]  V. Marks,et al.  The ageing entero-insular axis , 1998, Diabetologia.

[7]  A. Bado,et al.  The stomach is a source of leptin , 1998, Nature.

[8]  M. Horowitz,et al.  Effect of intravenous glucose and euglycemic insulin infusions on short-term appetite and food intake. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  J. Morley,et al.  Anorexia of aging: physiologic and pathologic. , 1997, The American journal of clinical nutrition.

[10]  M. Horowitz,et al.  Effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age. , 1997, The American journal of physiology.

[11]  Yang Wang,et al.  Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats. , 1997, The American journal of physiology.

[12]  T Reilly,et al.  Metabolic responses to isoenergetic meals containing different proportions of carbohydrate and fat , 1997, British Journal of Nutrition.

[13]  R. Ritter,et al.  Peptide cholesystokinin receptor antagonist increases food intake in rats , 1995, Appetite.

[14]  A. Masclee,et al.  Satiety effects of a physiological dose of cholecystokinin in humans. , 1995, Gut.

[15]  A. Masclee,et al.  Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. , 1994, Gut.

[16]  K. Pirke,et al.  Satiety and cholecystokinin. , 1994, The International journal of eating disorders.

[17]  C. Beglinger,et al.  Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. , 1992, Gastroenterology.

[18]  B. Vellas,et al.  Postprandial Cholecystokinin Secretion in Elderly with Protein‐Energy Undernutrition , 1992, Journal of the American Geriatrics Society.

[19]  J. Jansen,et al.  Evidence against autocrine feedback regulation of cholecystokinin secretion in man , 1992, Peptides.

[20]  F. Pi‐Sunyer,et al.  Effect of a soup preload on reduction of food intake by cholecystokinin in humans. , 1991, The American journal of physiology.

[21]  M. Classen,et al.  Effect of CCK on food intake in man: physiological or pharmacological effect? , 1991, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.

[22]  N. LaRusso,et al.  Physicochemical determinants in hepatic extraction of small peptides , 1990, Hepatology.

[23]  B. A. Baldwin,et al.  Effects of the CCK receptor antagonist MK-329 on food intake in pigs , 1990, Physiology & Behavior.

[24]  S. Peikin,et al.  Role of cholecystokinin in the control of food intake. , 1989, Gastroenterology clinics of North America.

[25]  N. Read,et al.  Gastrointestinal correlates of the development of hunger in man , 1989, Appetite.

[26]  H. Lieberman,et al.  Calorie and nutrient intakes of elderly and young subjects measured under identical conditions. , 1988, Journal of gerontology.

[27]  I. Goldfine,et al.  Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. , 1988, The Journal of clinical investigation.

[28]  J. Morley,et al.  Effect of gastrointestinal peptides on ingestion in old and young mice , 1988, Peptides.

[29]  J. Kleibeuker,et al.  Cholecystokinin is a physiological hormonal mediator of fat‐induced inhibition of gastric emptying in man , 1988, European journal of clinical investigation.

[30]  I. Goldfine,et al.  Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. , 1987, The Journal of clinical endocrinology and metabolism.

[31]  G. Greeley,et al.  Effect of aging on gallbladder contraction and release of cholecystokinin-33 in humans. , 1985, Surgery.

[32]  A. Stunkard,et al.  The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. , 1985, Journal of psychosomatic research.

[33]  J. Jansen,et al.  Radioimmunoassay of cholecystokinin in human tissue and plasma. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[34]  X. Pi-Sunyer,et al.  C-Terminal octapeptide of cholecystokinin decreases food intake in obese men , 1982, Physiology & Behavior.

[35]  C. Schneider,et al.  Cholecystokinin octapeptide decreases intake of solid food in man , 1982, Peptides.

[36]  G. P. Smith,et al.  C-terminal octapeptide of cholecystokinin decreases food intake in man. , 1981, The American journal of clinical nutrition.